What implants are associated with
Some implant complications are well established and uncontroversial. Others are reported by large numbers of women and are not yet settled science. This page separates the two, because conflating them helps nobody.
How to read this page
Every claim below carries a mark showing the strength of the evidence behind it. The mark describes the evidence, not how strongly anyone feels about it.
EstablishedEmergingContested
Implants are not lifetime devices
In October 2021 the FDA required a boxed warning on breast implants stating that they are not lifetime devices and that the chance of complications increases the longer they are in place. The same action restricted sale to providers who review a standardised patient decision checklist with the patient beforehand.
This is the single most useful fact for anyone weighing removal: further surgery at some point is the expected course, not a failure.
Capsular contracture
The body forms a capsule of scar tissue around any implant. In some people that capsule thickens and tightens, which can distort the breast’s shape and cause pain. It is one of the most common reasons for reoperation, and severity is graded on the Baker scale.
Rupture and silent rupture
Implant shells can fail. Saline rupture is usually obvious because the implant deflates. Silicone rupture frequently is not, which is why it is called silent rupture and why imaging is used to detect it rather than symptoms alone.
BIA-ALCL
Breast implant-associated anaplastic large cell lymphoma is a rare cancer of the immune system that arises in the capsule around an implant. It is associated predominantly with textured implants. It is treatable, and it is the one situation in which en bloc removal is specifically indicated.
Breast implant illness
Large numbers of women report a cluster of systemic symptoms they attribute to their implants: fatigue, cognitive fog, joint and muscle pain, rashes, hair loss, and new sensitivities. Many report improvement after removal. This is real experience, reported consistently, and it deserves to be taken seriously.
It is also not, at present, a formally defined diagnosis, and the causal mechanism is not established. Both of those things are true at once.
That breast implants cause a defined systemic illness is widely reported by patients but is not established in the medical literature. Breast implant illness is typically approached as a diagnosis of exclusion, meaning other causes are ruled out first.
That removal reliably resolves systemic symptoms is not established. Improvement after explant is commonly reported and is the subject of ongoing study, but outcomes vary and cannot be predicted for any individual.
Bacterial biofilm on implant surfaces and within capsules is documented, and its relationship to chronic inflammation is under active investigation. What it means for systemic symptoms is not yet clear.
Trace metals, including platinum, have been identified in implant shells and adjacent tissue. A 2025 systematic review concluded that current evidence does not support heavy metal toxicity as a justification for capsulectomy.
What we will not tell you
You will find sites claiming that implants harbour mould, that heavy metals are poisoning you, or that a detox protocol is needed to recover. Those claims are not supported, and the products sold alongside them are the reason the claims exist. We do not publish them, and we do not sell anything.
Dedicated pages for each topic are being written— capsular contracture, rupture and silent rupture, and BIA-ALCL will each get a full page with symptoms, imaging, and what the evidence supports. Each publishes once a physician has reviewed it.
- U.S. Food and Drug Administration. Breast implant labelling recommendations, boxed warning and patient decision checklist, October 2021.
- Breast Surgery Collaborative Community. Consensus statement on breast implant capsulectomy definitions and management, 2024.
- Aesthetic Plastic Surgery. Heavy metals in breast implants and implications for breast implant illness: a systematic review, 2025.